Clinical Trial Update: Long Acting Naltrexone for Opioid Addiction: Focus on Sustained Abstinence and Recovery [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating long-acting naltrexone for sustained abstinence and recovery in opioid-use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Long-acting naltrexone (naltrexone)

Snippet

Sponsor: Lars Tanum | Conditions: Opioid-use Disorder | Phase 4 | Status: COMPLETED